Is COVID-19 All That Glitters?

Over the last three years, the Coronavirus-19 disease has been a global health emergency, playing a primary role in the international scientific community. Clinical activity and scientific research have concentrated their efforts on facing the pandemic, allowing the description of novel pathologies correlated to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), such as the Multisystemic Inflammatory Syndrome in Children and Adults (MIS-C, MIS-A). Conversely, this shift of attention to COVID-19 disease and its complications could, in some cases, have delayed and underestimated the diagnosis of diseases not associated with SARS-CoV-2, including rare diseases. Here we describe the diagnostic process that led to the definition of a rare vasculitis in a young woman with a recent clinical history of SARS-CoV-2.

Automated summary

Over the past three years, the Coronavirus-19 disease has emerged as a global health emergency, drawing significant attention from the international scientific community. Efforts have been focused on understanding and addressing the pandemic, leading to the discovery of new pathologies related to SARS-CoV-2, such as MIS-C and MIS-A. However, this heightened focus on COVID-19 may have inadvertently impacted the diagnosis of unrelated diseases, including rare conditions. This article describes the diagnostic process of a rare vasculitis in a young woman with a recent clinical history of SARS-CoV-2.